Histone Methyltransferase Inhibitors: Novel Epigenetic Agents for Cancer Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|2|167-185

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.2, 2013-01, pp. : 167-185

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors

By  

Current Cancer Drug Targets, Vol. 12, Iss. 4, 2012-04 ,pp. : 439-452

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetic cancer therapies: DNA methyltransferase inhibitors

By Brown Robert   Strathdee Gordon  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 747-754

Informa Healthcare

Access to resources Recommend Favorite

DNA Methyltransferase-1 Inhibitors as Epigenetic Therapy for Cancer

By  

Current Cancer Drug Targets, Vol. 13, Iss. 4, 2013-05 ,pp. : 379-399

Bentham Science Publishers

Access to resources Recommend Favorite

Histone deacetylase inhibitors: novel anticancer agents

By Saunders N.A.   Popa C.   Serewko M.M.   Jones S.J.   Dicker A.J.   Dahler A.L.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1611-1621

Informa Healthcare

Access to resources Recommend Favorite

Aromatase inhibitors and other novel agents in breast cancer treatment

By Saji Shigehira   Toi Masakazu  

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 303-319

Informa Healthcare

Access to resources Recommend Favorite